Molecular strategies targeting the host component of cancer to enhance tumor response to radiation therapy

Dong Wook Kim, Jessica Huamani, Allie Fu, Dennis E. Hallahan

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

The tumor microenvironment, in particular, the tumor vasculature, as an important target for the cytotoxic effects of radiation therapy is an established paradigm for cancer therapy. We review the evidence that the phosphoinositide 3-kinase (PI3K)/Akt pathway is activated in endothelial cells exposed to ionizing radiation (IR) and is a molecular target for the development of novel radiation sensitizing agents. On the basis of this premise, several promising preclinical studies that targeted the inhibition of the PI3K/Akt activation as a potential method of sensitizing the tumor vasculature to the cytotoxic effects of IR have been conducted. An innovative strategy to guide cytotoxic therapy in tumors treated with radiation and PI3K/Akt inhibitors is presented. The evidence supports a need for further investigation of combined-modality therapy that involves radiation therapy and inhibitors of PI3K/Akt pathway as a promising strategy for improving the treatment of patients with cancer.

Original languageEnglish (US)
Pages (from-to)38-46
Number of pages9
JournalInternational Journal of Radiation Oncology Biology Physics
Volume64
Issue number1
DOIs
StatePublished - Jan 1 2006

Fingerprint

1-Phosphatidylinositol 4-Kinase
radiation therapy
Radiotherapy
tumors
cancer
therapy
sensitizing
ionizing radiation
inhibitors
Neoplasms
Ionizing Radiation
Radiation-Sensitizing Agents
radiation
Combined Modality Therapy
Tumor Microenvironment
activation
Therapeutics
Endothelial Cells
Radiation

Keywords

  • Akt
  • Combined modality therapy
  • Endothelium
  • Radiation sensitizer
  • Vasculature targeted therapy

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

Molecular strategies targeting the host component of cancer to enhance tumor response to radiation therapy. / Kim, Dong Wook; Huamani, Jessica; Fu, Allie; Hallahan, Dennis E.

In: International Journal of Radiation Oncology Biology Physics, Vol. 64, No. 1, 01.01.2006, p. 38-46.

Research output: Contribution to journalArticle

Kim, Dong Wook ; Huamani, Jessica ; Fu, Allie ; Hallahan, Dennis E. / Molecular strategies targeting the host component of cancer to enhance tumor response to radiation therapy. In: International Journal of Radiation Oncology Biology Physics. 2006 ; Vol. 64, No. 1. pp. 38-46.
@article{4230bae2f49d49de94431244a251774c,
title = "Molecular strategies targeting the host component of cancer to enhance tumor response to radiation therapy",
abstract = "The tumor microenvironment, in particular, the tumor vasculature, as an important target for the cytotoxic effects of radiation therapy is an established paradigm for cancer therapy. We review the evidence that the phosphoinositide 3-kinase (PI3K)/Akt pathway is activated in endothelial cells exposed to ionizing radiation (IR) and is a molecular target for the development of novel radiation sensitizing agents. On the basis of this premise, several promising preclinical studies that targeted the inhibition of the PI3K/Akt activation as a potential method of sensitizing the tumor vasculature to the cytotoxic effects of IR have been conducted. An innovative strategy to guide cytotoxic therapy in tumors treated with radiation and PI3K/Akt inhibitors is presented. The evidence supports a need for further investigation of combined-modality therapy that involves radiation therapy and inhibitors of PI3K/Akt pathway as a promising strategy for improving the treatment of patients with cancer.",
keywords = "Akt, Combined modality therapy, Endothelium, Radiation sensitizer, Vasculature targeted therapy",
author = "Kim, {Dong Wook} and Jessica Huamani and Allie Fu and Hallahan, {Dennis E.}",
year = "2006",
month = "1",
day = "1",
doi = "10.1016/j.ijrobp.2005.02.008",
language = "English (US)",
volume = "64",
pages = "38--46",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Molecular strategies targeting the host component of cancer to enhance tumor response to radiation therapy

AU - Kim, Dong Wook

AU - Huamani, Jessica

AU - Fu, Allie

AU - Hallahan, Dennis E.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - The tumor microenvironment, in particular, the tumor vasculature, as an important target for the cytotoxic effects of radiation therapy is an established paradigm for cancer therapy. We review the evidence that the phosphoinositide 3-kinase (PI3K)/Akt pathway is activated in endothelial cells exposed to ionizing radiation (IR) and is a molecular target for the development of novel radiation sensitizing agents. On the basis of this premise, several promising preclinical studies that targeted the inhibition of the PI3K/Akt activation as a potential method of sensitizing the tumor vasculature to the cytotoxic effects of IR have been conducted. An innovative strategy to guide cytotoxic therapy in tumors treated with radiation and PI3K/Akt inhibitors is presented. The evidence supports a need for further investigation of combined-modality therapy that involves radiation therapy and inhibitors of PI3K/Akt pathway as a promising strategy for improving the treatment of patients with cancer.

AB - The tumor microenvironment, in particular, the tumor vasculature, as an important target for the cytotoxic effects of radiation therapy is an established paradigm for cancer therapy. We review the evidence that the phosphoinositide 3-kinase (PI3K)/Akt pathway is activated in endothelial cells exposed to ionizing radiation (IR) and is a molecular target for the development of novel radiation sensitizing agents. On the basis of this premise, several promising preclinical studies that targeted the inhibition of the PI3K/Akt activation as a potential method of sensitizing the tumor vasculature to the cytotoxic effects of IR have been conducted. An innovative strategy to guide cytotoxic therapy in tumors treated with radiation and PI3K/Akt inhibitors is presented. The evidence supports a need for further investigation of combined-modality therapy that involves radiation therapy and inhibitors of PI3K/Akt pathway as a promising strategy for improving the treatment of patients with cancer.

KW - Akt

KW - Combined modality therapy

KW - Endothelium

KW - Radiation sensitizer

KW - Vasculature targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=29244431955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29244431955&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2005.02.008

DO - 10.1016/j.ijrobp.2005.02.008

M3 - Article

C2 - 16377414

AN - SCOPUS:29244431955

VL - 64

SP - 38

EP - 46

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 1

ER -